Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ding, zhenyu
HX-LION, NCT06603402: Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC	Recruiting	2	41	RoW	low-dose involved-field radiotherapy combined with immunochemotherapy	Sichuan University	Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy	03/25	09/25
NCT06403878: Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer	Recruiting	2	68	RoW	Carboplatin, Nab paclitaxel, Sintilimab	Sichuan University	Esophageal Cancer	05/26	08/26
NCT06675201: Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma	Recruiting	2	165	RoW	neoantigen-loaded dendritic cell vaccine (NeoDC-Vac)	Sichuan University	Esophageal Squamous Cell Carcinoma (ESCC), Neoantigen-loaded Dendritic Cell Vaccine, Immune Checkpoint Inhibitors (ICIs)	10/27	10/27